StockData
SeaStar Medical Holding Corp logo

SeaStar Medical Holding Corp (ICUCW) stock analysis

ICUCWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 3/309% above fair value
$0.01−0.01 (-34.73%)

Close on Oct 30, 2026Market cap $9.87MP/E –Yield –

StockData Score

Prices as of Oct 30, 2026How the score works

Value1Growth1Performance0Health1Dividend0

Weak3 of 30 checks passed

SeaStar Medical passes 3 of the 30 checks behind our score; 19 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
1/6
Past performance
0/6
Financial health
1/6
Dividend
0/6

What stands out

  • P/B below the industry

    SeaStar Medical's price-to-book of 2.30 is below the Surgical, Medical, and Dental Instruments and Supplies median of 3.11.

  • Growing faster than the industry

    Revenue grew 124% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 10.4%.

  • Short-term assets cover short-term debts

    Current assets are 1.89 times current liabilities.

What to watch

  • Margin of safety under 20%

    The price is 9.2% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $2.24 is above our fair value estimate of $2.05.

  • Interest not well covered

    Operating income covers interest expense -518.1 times; we look for at least 5.

  • Elevated bankruptcy risk

    The Altman Z-score is -28.97; above 3 is the safe zone and below 1.8 the distress zone.

Valuation1/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B below the industry

    SeaStar Medical's price-to-book of 2.30 is below the Surgical, Medical, and Dental Instruments and Supplies median of 3.11.

  • Trading above fair value

    The share price of $2.24 is above our fair value estimate of $2.05.

  • Margin of safety under 20%

    The price is 9.2% above fair value, so there is no margin of safety.

Growth1/6

  • Revenue growth over 3 years

    Needs three years of positive revenue.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 124% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 10.4%.

  • Guidance unchanged

    The latest outlook (2026 net product revenue, May 13, 2026) was maintained, so it neither adds nor takes away points.

  • Gross margin slipping

    Gross margin was 92.6% over the last twelve months, against 96.5% a year earlier.

Past performance0/6

  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity below the industry

    SeaStar Medical's return on equity of -357% is below the Surgical, Medical, and Dental Instruments and Supplies median of -35.2%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin against its history

    Needs five years of revenue and net income.

  • Net margin below the industry

    SeaStar Medical's net margin of -796% is below the Surgical, Medical, and Dental Instruments and Supplies median of -15.8%.

Financial health1/6

  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt coverage

    Needs operating cash flow.

  • Interest not well covered

    Operating income covers interest expense -518.1 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 1.89 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is -28.97; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6

  • No dividend

    SeaStar Medical has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

Our estimate per share

$2.05

The share price is 9% above this estimate.

20%+ below
Near fair value
20%+ above
$2.24Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/B3.1×–3.1×$3.0350%
P/S2.7×–2.7×$1.0750%
Fair value$2.05100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/B at month end
  • Surgical, Medical, and Dental Instruments and Supplies median 3.1

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day
$666.24K
Value traded per 1% price move
$61.80K

Downside

High risk

Typical loss in a bad month
42.7%
Volatility (annualized)
112%
Sharpe ratio, 1 year
-0.58
Beta to the S&P 500 (5Y)
0.86

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2020 to 2025

Gross margin

95.7%

Operating margin

-986.6%

Net margin

-984.6%